SHINE Expands Patent Portfolio

2017-09-28T15:21:53+00:00

U.S. Patent No. 9,734,926 relates to producing medical isotopes and expires December 23, 2032. This achievement demonstrates SHINE’s ongoing commitment to innovation and leadership in the medical isotope industry.

SHINE Expands Patent Portfolio 2017-09-28T15:21:53+00:00

Grand Opening of new SHINE Global HQ

2017-08-01T08:31:03+00:00

January 16, 2017 - SHINE Medical Technologies, Inc. (SHINE), a company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, held a ribbon cutting ceremony to celebrate the grand opening of the company’s new global headquarters in downtown Janesville, Wisconsin. The ribbon cutting was led by the John Beckord and the Forward Janesville Goodwill Ambassadors.

Grand Opening of new SHINE Global HQ 2017-08-01T08:31:03+00:00

SHINE Awarded $20.9M DOE/NNSA Phase II

2017-08-01T08:35:37+00:00

December 12, 2016 - SHINE Medical Technologies announced today that it has been awarded $10 million from the U.S. Department of Energy’s National Nuclear Security Administration (DOE/NNSA) as part of a $20.9 million cooperative agreement.

SHINE Awarded $20.9M DOE/NNSA Phase II 2017-08-01T08:35:37+00:00

NRC Issues SHINE Construction Permit

2017-10-16T08:36:46+00:00

February 25, 2016 - SHINE Medical Technologies, Inc., a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical tracers and cancer treatment elements, announced today that the U.S. Nuclear Regulatory Commission (NRC) has authorized issuance of the SHINE construction permit.

NRC Issues SHINE Construction Permit 2017-10-16T08:36:46+00:00